Cell Culture Technology– category –
-
BioProcess International Reports on Mesenchymal Stem Cell (MSC) Large-Volume Manufacturing Challenges and Corning HYPERStack™ Contribution
BioProcess International USA Overview BioProcess International reported on the challenges and progress in large-volume manufacturing of mesenchymal stem cells (MSCs). The approval of two iPSC-derived therapies in Japan indicates growing ... -
New Market Pitch Evaluates Top Cell Therapy Startups Including Orca Bio, Cellares, and Kelonia: Differentiated by Clinical, Manufacturing, and Strategic Advancements
New Market Pitch USA Overview New Market Pitch selected ten leading cell therapy startups—Orca Bio, Kyverna, Cabaletta Bio, Cellares, Immatics, Iovance, Sana, Kelonia, Orna, and Dispatch Bio—evaluating their regulatory maturity, clinical... -
Cellbase Emphasizes Critical Role of Real-Time Monitoring Tools for Bioreactor Scale-Up
Cellbase Germany Overview Cellbase highlighted the imperative of integrating real-time monitoring tools for successful bioreactor scale-up. As bioreactor scale increases, single-point monitoring becomes inadequate, leading to mixing dela... -
VIVEbiotech Reaches 15 In Vivo Lentiviral Vector Programs, Fortifying Gene Therapy Manufacturing Leadership
BioPharma BoardRoom スペイン Overview VIVEbiotech has significantly advanced its position in gene therapy manufacturing by adding its 15th in vivo lentiviral vector (LVV) therapeutic program. This milestone underscores the company's robu... -
Nkarta Accelerates Clinical Development of Off-the-Shelf NK Cell Therapies NKX019 and NKX101 from Healthy Donors
Umbrex USA Overview Nkarta, a clinical-stage biotechnology company, focuses on off-the-shelf natural killer (NK) cell therapies, utilizing a platform that genetically engineers and cryopreserves healthy donor-derived NK cells. Its lead p... -
Pharma 4.0 Drives Digital Integration: LIMS, AI, and Digital Twins Revolutionize Pharmaceutical Manufacturing
Technology Networks UK Overview Pharma 4.0 is advancing digital integration, leveraging LIMS, AI algorithms, and digital twin technology to eliminate data silos and foster connected pharmaceutical manufacturing. Digital twins extend the ... -
BioProcess International Advocates for Distributed Hybrid Model in Autologous Cell Therapy Manufacturing
BioProcess International USA Overview A BioProcess International video roundtable discussed the future of distributed biomanufacturing for autologous cell therapies. With centralized manufacturing struggling to scale and point-of-care mo... -
PAT Revolutionizes Biomanufacturing QA: Raman/NIR Spectroscopy and Inline Probes Enhance Real-Time Monitoring
Technology Networks UK Overview Process Analytical Technology (PAT) is transforming biomanufacturing quality assurance through real-time monitoring. PAT tools, including Raman and NIR spectroscopic sensors, inline probes, and chemometric... -
Frontiers Reports GMP-Compliant Scalable Manufacturing Platform Established for Allogeneic Type 1 Regulatory T Cells (TRX103)
Frontiers in Immunology Switzerland Overview A study published in Frontiers reports the establishment of a GMP-compliant, scalable manufacturing platform for TRX103, an allogeneic Type 1 regulatory T cell (Tr1 cell). While TRX103 has sho... -
Raman Spectroscopy Outperforms NIR for Glucose/Lactate Monitoring in Bioprocess, Becomes Industry Standard
Technology Networks UK Overview Raman spectroscopy has demonstrated superior selectivity and predictive accuracy compared to Near-Infrared (NIR) spectroscopy for real-time monitoring of glucose and lactate in mammalian cell cultures. Thi...
